Navigation Links
One Strain Behind Epidemic of Staph Infections
Date:1/21/2008

Government study found most MRSA infections in community linked to single evolving bacterium

MONDAY, Jan. 21 (HealthDay News) -- A single strain of an evolving bacterium has been responsible for most of the community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections that have spread rapidly in the United States during the past five years, a new government study finds.

Typically, CA-MRSA causes boils, but it can lead to life-threatening conditions that are difficult to treat, according to the study.

The National Institute of Allergy and Infectious Diseases (NIAID) researchers said their findings resolve debate about the molecular evolution of CA-MRSA in the United States and rule out the possibility that multiple strains of USA300 emerged randomly with similar characteristics.

This single strain of USA300, which has spread with "extraordinary transmissibility" in the past five years, was identified by analyzing the genomes of USA300 collected from 10 patients infected in different parts of the United States between 2002 and 2005. Eight of the 10 samples had almost identical genomes, indicating they were from a common strain. The remaining two were related to the other eight, but more distantly.

The researchers also found that two of the eight almost identical USA300 samples caused far fewer deaths in laboratory mice than the other samples. This appears to support an emerging belief that tiny genetic changes among evolving strains have a major impact on disease severity and the potential for development of drug resistance.

The study was published in this week's online issue of the Proceedings of the National Academy of Sciences.

"The USA300 group of strains appears to have extraordinary transmissibility and fitness," research leader Frank R. DeLeo said in a prepared statement. "We anticipate that new USA300 derivatives will emerge within the next several years and that these strains will have a wide range of disease-causing potential."

It's hoped this research will lead to new test that can quickly identify specific MRSA strains.

A second study, led by the same NIAID scientists, discovered new information about how MRSA bacteria -- including the USA300 group -- avoid destruction by the human immune system's white blood cells. The study found that MRSA senses danger and turns the tables, killing the white blood cells.

That study was recently published online in The Journal of Immunology.

"Scientists are pressing ahead quickly to learn more about how some MRSA strains evade the immune system and spread quickly. The information presented in these two studies adds important new insights into that expanding knowledge base," NIAID Director Dr. Anthony S. Fauci said in a prepared statement.

More information

The U.S. Centers for Disease Control and Prevention has more about MRSA.



-- Robert Preidt



SOURCE: National Institute of Allergy and Infectious Diseases, news release, Jan. 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Computer-Related Eye Strain Not Just for Adults
2. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
3. K-State Veterinary Lab Routinely Tests For Bluetongue Virus; Lab Director Says Strains Found in Kansas, U.S. Usually Less-Virulent
4. Chronic job strain doubles the risk of a second heart attack
5. High and mighty: first common height gene identified by researchers behind obesity gene finding
6. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
7. The science behind the food we eat and the earth on which it grows
8. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
9. Second pathway behind HIV-associated immune system dysfunction identified
10. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
11. P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
One Strain Behind Epidemic of Staph Infections
(Date:8/16/2017)... ... August 16, 2017 , ... An August 3rd article on Reuters covers ... of a report in JAMA (the Journal of the American Medical Association). The study found ... to achieve BMIs under 30, when compared to patients with lower BMIs. At present, weight ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
(Date:8/16/2017)... Brentwood, TN (PRWEB) , ... August 16, 2017 ... ... market-leading dermatology practice partnerships through affiliations and de novo development, today announced ... practice. , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage ...
(Date:8/16/2017)... ... 16, 2017 , ... Paul Vitenas, MD, FACS , is honored to ... annual list identifies the nation’s top physicians, in a variety of specialties. This marks ... top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: